Treace Medical Concepts Inc (TMCI)
7.83
-0.11
(-1.39%)
USD |
NASDAQ |
Nov 22, 16:00
7.83
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts Cash from Investing (Quarterly): 5.763M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.763M |
| June 30, 2024 | 22.43M |
| March 31, 2024 | 3.758M |
| December 31, 2023 | 5.007M |
| September 30, 2023 | 4.597M |
| June 30, 2023 | -10.42M |
| March 31, 2023 | -80.48M |
| December 31, 2022 | -64.01M |
| September 30, 2022 | -5.857M |
| June 30, 2022 | -5.168M |
| Date | Value |
|---|---|
| March 31, 2022 | -1.481M |
| December 31, 2021 | -0.90M |
| September 30, 2021 | -0.939M |
| June 30, 2021 | -0.67M |
| March 31, 2021 | -0.196M |
| December 31, 2020 | -0.088M |
| September 30, 2020 | -0.058M |
| June 30, 2020 | -0.249M |
| March 31, 2020 | -0.674M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-80.48M
Minimum
Mar 2023
22.43M
Maximum
Jun 2024
-6.823M
Average
-0.67M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -2.172B |
| Perspective Therapeutics Inc | -29.74M |
| Retractable Technologies Inc | 2.926M |
| Xtant Medical Holdings Inc | -2.009M |
| Catheter Precision Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.84M |
| Cash from Financing (Quarterly) | 0.008M |
| Free Cash Flow | -43.20M |
| Free Cash Flow Per Share (Quarterly) | -0.2363 |
| Free Cash Flow to Equity (Quarterly) | -14.78M |
| Free Cash Flow Yield | -8.90% |